A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine

PHASE3CompletedINTERVENTIONAL
Enrollment

1,923

Participants

Timeline

Start Date

March 24, 2021

Primary Completion Date

December 30, 2021

Study Completion Date

December 30, 2021

Conditions
SARS-CoV-2 Infection
Interventions
BIOLOGICAL

Moderna COVID-19 Vaccine

A lipid nanoparticle (LNP) dispersion of a messenger ribonucleic acid (mRNA) encoding the prefusion stabilized S protein of SARS-CoV-2 formulated in LNPs composed of 4 lipids (1 proprietary and 3 commercially available). It is a suspension for intramuscular injection administered as a series of two doses (0.5 mL each) 1 month apart.

Trial Locations (51)

10016

NYU Bellevue Vaccine Center, New York

10027

Harlem Prevention Center CRS, New York

10065

New York Blood Center CRS, New York

10451

Bronx Prevention Research Center CRS, The Bronx

11501

NYU Long Island Vaccine Center, Mineola

11794

Stony Brook University, Stony Brook

22908

University of Virginia, Charlottesville

27157

Wake Forest University, Winston-Salem

27599

University of North Carolina, Chapel Hill

29634

Clemson University, Clemson

30030

The Hope Clinic of the Emory Vaccine Center CRS, Decatur

30310

Morehouse University, Atlanta

32209

UF CARES, Jacksonville

32610

University of Florida, Gainesville

32803

Orlando Immunology Center CRS, Orlando

33462

JEM Headlands LLC, Atlantis

33612

University of South Florida, Tampa

34243

Headlands Research Sarasota, Sarasota

35222

Alabama CRS, Birmingham

37232

Vanderbilt Vaccine CRS, Nashville

40536

University of Kentucky, Lexington

48201

Wayne State - Harper Hospital, Detroit

55455

University of Minnesota, Minneapolis

60208

Northwestern University, Evanston

60612

Rush University CRS, Chicago

61820

Champaign-Urbana Public Health District, Champaign

63110

Washington University Therapeutics CRS, St Louis

65201

Columbia - Missouri VTEU, Columbia

67214

Univ, of Kansas School of Medicine CRS, Wichita

68105

University of Nebraska, Omaha

70601

Centex Studies, Inc. - Lake Charles, Lake Charles

77058

Centex Studies, Inc. - Houston, Houston

77090

Centex Studies, Inc. - Westfield, Houston

77843

Texas A&M University, College Station

Texas A&M - Kingsville, Kingsville

78526

Centex Studies, Inc. - Brownsville, Brownsville

79106

Texas Tech, Amarillo

80301

University of Colorado- Boulder, Boulder

85260

Headlands Research Scottsdale, Scottsdale

85281

AMR Phoenix, Tempe

85724

University of Arizona, Tucson

87131

University of New Mexico, Albuquerque

89119

AMR Las Vegas, Las Vegas

90059

Charles Drew University, Los Angeles

92103

University of California, San Diego, San Diego

95817

UC Davis, Sacramento

98109

University of Washington, Seattle

47405-7000

Indiana University, Bloomington

20742-2611

University of Maryland College Park, College Park

02215-4302

Fenway Health (FH) CRS, Boston

02904

The Miriam Hopsital CRS, Providence

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT04811664 - A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine | Biotech Hunter | Biotech Hunter